Search

Your search keyword '"Cotteret, Camille"' showing total 25 results
Start Over Author "Cotteret, Camille"
25 results on '"Cotteret, Camille"'

4. Self-application of aminoglycoside-based creams to treat cutaneous leishmaniasis in travelers

Author

Mouri, Oussama, primary, Melenotte, Cléa, additional, Guéry, Romain, additional, Cotteret, Camille, additional, Schweitzer-Chaput, Arnaud, additional, Perignon, Alice, additional, Thellier, Marc, additional, Bourrat, Emmanuelle, additional, Kaguelidou, Florentia, additional, Siriez, Jean Yves, additional, Malvy, Denis, additional, Gangneux, Jean-Pierre, additional, Duvignaud, Alexandre, additional, Ravel, Christophe, additional, Cisternino, Salvatore, additional, Ransom, Janet, additional, Caumes, Eric, additional, Lortholary, Olivier, additional, Grogl, Max, additional, and Buffet, Pierre, additional

Published
2023
Full Text
View/download PDF

7. Indications and Safety of Rituximab in Pediatric Neurology: A 10-Year Retrospective Study

Author

Nguyen, Ai Tien, primary, Cotteret, Camille, additional, Durrleman, Chloé, additional, Barnerias, Christine, additional, Hully, Marie, additional, Gitiaux, Cyril, additional, Mesples, Bettina, additional, Bustamante, Jacinta, additional, Chhun, Stéphanie, additional, Fayard, Claire, additional, Cisternino, Salvatore, additional, Treluyer, Jean-Marc, additional, Desguerre, Isabelle, additional, and Aubart, Mélodie, additional

Published
2022
Full Text
View/download PDF

8. Setting up of a hospital Covid‐19 vaccination center: A descriptive study

Author

Wise, Scarlett, primary, Lanternier, Fanny, additional, Cotteret, Camille, additional, Chasport, Céline, additional, Juin‐Leonard, Virginie, additional, Cantat, Amélie, additional, Scemla, Anne, additional, Delage, Claire, additional, Mantz, Barbara, additional, Telion, Caroline, additional, Carli, Pierre, additional, Frange, Pierre, additional, and Cisternino, Salvatore, additional

Published
2022
Full Text
View/download PDF

9. Extensive dermatophytosis caused by terbinafine-resistant Trichophyton indotineae, successfully treated with topical voriconazole

Author

Gueneau, Romain, primary, Joannard, Brune, additional, Haddad, Naeda, additional, Alby, Fanny, additional, Jullien, Vincent, additional, Schlatter, Joel, additional, Cotteret, Camille, additional, Bougnoux, Marie Elisabeth, additional, Lanternier, Fanny, additional, Laroche, Liliane, additional, Delliere, Sarah, additional, Cisternino, Salvatore, additional, and Lortholary, Olivier, additional

Published
2022
Full Text
View/download PDF

12. Stability and Formulation of Erlotinib in Skin Creams

Author

Nguyen, David, primary, Secrétan, Philippe-Henri, additional, Cotteret, Camille, additional, Jacques-Gustave, Emmanuelle, additional, Greco, Céline, additional, Bodemer, Christine, additional, Schlatter, Joel, additional, and Cisternino, Salvatore, additional

Published
2022
Full Text
View/download PDF

13. Setting up of a hospital Covid‐19 vaccination center: A descriptive study.

Author

Wise, Scarlett, Lanternier, Fanny, Cotteret, Camille, Chasport, Céline, Juin‐Leonard, Virginie, Cantat, Amélie, Scemla, Anne, Delage, Claire, Mantz, Barbara, Telion, Caroline, Carli, Pierre, Frange, Pierre, and Cisternino, Salvatore

Subjects
COVID-19 vaccines, COVID-19, SARS-CoV-2, COVID-19 pandemic, MEDICAL personnel
Abstract

Background and Aims: The coronavirus pandemic challenged countries worldwide in a race against contaminations and variants. Vaccination campaigns were the answer to such an infectious spread. This descriptive study presents the organizational process of the setting up of a Covid‐19 vaccination center in a French University Hospital in January 2021, the issues encountered along the way and assessment of adaptability. Methods: Three major stakeholders: SARS CoV‐2 crisis referent, referring vaccination medical doctor and referring vaccination pharmacist retraced key moments and identified issues encountered during the setting up of the vaccination center and its long term maintenance, threw a series of meetings. Records of crisis and periodic meetings that took place threw out the vaccination campaign were consulted. Results: A multidisciplinary crisis steering committee with nine different professionals was created January 3. Logistics for the vaccination center opening were discussed: location, informatics, appointment‐scheduling, pharmaceutical circuit, internal circuit, human resources, and information communication. The vaccination center was ready to welcome healthcare workers in less than 24 h on January 4. The first month, 2757 1st shots were administered, leading up to a total of 9167 1st shots during 6 months of activity. From January to June 2021, the multidisciplinary group dealt and adapted its processes to challenging and unexpected situations. Indeed, issues encountered with Pfizer BioNTech's and AstraZeneca's vaccine, were: supply shortages, vaccine manipulation, targeted populations, pharmacovigilance, and general communication. Conclusion: This descriptive study provides an exclusive insight on how a hospital vaccination center was organized and adapted during Covid‐19 pandemic to ensure healthcare workers' security and resilience, and to protect high risk patients of severe Covid‐19 infection. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

19. Topical 1% Voriconazole for Mixed Scedosporium and Exophiala Subcutaneous Infection in a Kidney Transplant Recipient.

Author

PACCOUD, Olivier, SOHIER, Pierre, COTTERET, Camille, GUÉGAN, Sarah, and LANTERNIER, Fanny

Subjects
VORICONAZOLE, KIDNEY transplantation, BK virus, JOB'S syndrome, DERMATOMYCOSES
Abstract

The article focuses on the management challenges of subcutaneous hyalohyphomycoses and phaeohyphomycoses in solid-organ transplant recipients, presenting a case of mixed subcutaneous infection caused by Scedosporium and Exophiala in a renal transplant recipient successfully treated with a combination of systemic antifungals and topical 1 present voriconazole.

Published
2023
Full Text
View/download PDF

24. A Comparative Analysis of Antibiotic and Antiviral Drug Use in Pediatrics and ObstetricsGynecology over 12 years (2000-2001, 2005-2006 and 2012-2013) using Defined Daily Doses and Days of Therapy

Author

Cotteret, Camille, Guillot-Froger, Justine, Schott, Alexia, Lebel, Denis, Roy, Hélène, Ovetchkine, Philippe, and Bussières, Jean-François

Subjects
Dose définie journalière, Antibiotique, Pédiatrie, Surveillance de l'usage des antimicrobiens, Jour de traitement, Antiviral
Abstract

Background: There are limited data published about antibiotics and antiviral consumption in terms of Defined Daily Doses (DDD) and Days Of Therapy (DOT) in Pediatrics and ObstetricsGynecology. Objectives: To characterize and quantify antimicrobial drug use as DDD/1000 patient-days per molecule, DOT/1000 patient-days per molecule, and mean dose (mg/kg/day) per molecule over a twelve-year period and explore the changes over time in Pediatrics and Obstetrics-Gynecology. Methods: Retrospective, cross-sectional, descriptive study, in a mother-child University Hospital Center, with 400 pediatric beds and 100 obstetric-gynecology beds. All inpatient (in Pediatrics and Obstetrics-Gynecology) who received one of the 51 authorized antibiotics or one of the 9 authorized antivirals on the institution’s local formulary in 2000-2001, 2005-2006 and 2012-2013 were included. Prescriptions from the emergency room and outpatient clinics were excluded. Data were extracted from the patients’ computerized medication profiles. We calculated DDD/1000 patient-days per molecule, DOT/1000 patient-days per molecule overall and for each molecule. The mean dose in mg/kg/day was calculated for each molecule for the ranges: ≤ 1.5 kg; > 1.5-5 kg; > 5-15 kg; > 15-30 kg; and > 30 kg. Results: Over 12 years: there was a 1.67-fold increase for antibiotics and a 3.77-fold increase for antivirals in the overall number of DDD/1000 patient-days. There was a 1.73-fold increase for antibiotics and a 2.57-fold increase for antivirals in the overall number of DOT/1000 patientdays. It reveals increases in dosage regimens for amoxicillinclavulanic acid, gentamicin, piperacillin, piperacillin-tazobactam, and ticarcillin-clavulanic acid. Nevertheless, azithromycin and erythromycin dosage regimens decrease. The antivirals data reveals no predictable tendencies. Conclusion: This retrospective, cross-sectional, descriptive study reported the use of anti-infectious drugs at a mother-child hospitalover a 12-year time period. Both the overall numbers of DDD/1000 patient-days and the DOT/1000 patient-days increased. It should be monitored on a continuous basis by antimicrobial stewardship program in healthcare settings.

Published
2015
Full Text
View/download PDF

25. Physicochemical Stability Study of Oral Suspension Containing Ruxolitinib in Children with Steroid-Refractory Acute Graft-Versus-Host Disease.

Author

Hinterlang M, Sebti M, Cotteret C, Vidal F, Neven B, Cisternino S, and Schlatter J

Subjects
Administration, Oral, Child, Chromatography, High Pressure Liquid, Drug Compounding methods, Drug Stability, Drug Storage, Humans, Nitriles, Pyrazoles, Pyrimidines, Steroids, Suspensions, Tablets, Graft vs Host Disease drug therapy
Abstract

Ruxolitinib, used in children with steroid-refractory acute graft-versus-host (GVH) disease, is currently commercially available only as a tablet adult dosage. For the paediatric population, an oral liquid would be an adapted dosage formulation. The aim of this study was to develop ruxolitinib compounded oral suspensions at 2 mg/mL by using commercial tablets in available aqueous vehicle (Inorpha) and to measure its stability at both room temperature and under refrigeration. Chemical stability of suspensions containing ruxolitinib was evaluated for 60 days based on pH, degradation, and drug content. Physical stability of the drug suspension was evaluated by visual aspect and odour. The remaining ruxolitinib concentration of the suspension was at least 95% of the initial concentration after 60 days at both temperatures. The pH, colour, and odour of the suspensions throughout the study remained unchanged with respect to the initial time point., Competing Interests: The authors declare that there are no conflicts of interest., (Copyright © 2022 Mélanie Hinterlang et al.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results